Chronic Fatigue Therapy
- Product NDC
- 17312-170
- 11-digit product format
- 173120170
- Labeler code
- 17312
- Product ID
- 17312-170_4604f3de-7763-ddaa-e063-6394a90a78d0
- Type
- HUMAN OTC DRUG
- Nonproprietary name
- EPINEPHRINE, GOLD, CHELIDONIUM MAJUS, ECHINACEA, GINKGO, HELLEBORUS NIGER, PHOSPHORIC ACID, SCUTELLARIA LATERIFLORA, THUJA OCCIDENTALIS
- Dosage form
- TABLET, ORALLY DISINTEGRATING
- Route
- ORAL
- Labeler
- TRP Company
- Marketing category
- UNAPPROVED HOMEOPATHIC
- Marketing start
- 2018-08-20
- Substance
- CHELIDONIUM MAJUS; ECHINACEA, UNSPECIFIED; EPINEPHRINE; GINKGO; GOLD; HELLEBORUS NIGER ROOT; PHOSPHORIC ACID; SCUTELLARIA LATERIFLORA; THUJA OCCIDENTALIS LEAFY TWIG
- Active strength
- 6; 3; 7; 3; 8; 6; 6; 6; 6 [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1
- Pharmacologic classes
- Adrenergic alpha-Agonists [MoA], Adrenergic beta-Agonists [MoA], Allergens [CS], Catecholamine [EPC], Catecholamines [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Standardized Chemical Allergen [EPC], alpha-Adrenergic Agonist [EPC], beta-Adrenergic Agonist [EPC]
- NDC exclude flag
- No
- Listing certified through
- 2026-12-31
- Current FDA listing
- Yes
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- Chronic Fatigue Therapy
- Listing expiration
- 2026-12-31
Active Ingredients#
Ingredient, Strength table| Ingredient | Strength |
|---|
| CHELIDONIUM MAJUS | 6 [hp_X]/1 |
| ECHINACEA, UNSPECIFIED | 3 [hp_X]/1 |
| EPINEPHRINE | 7 [hp_X]/1 |
| GINKGO | 3 [hp_X]/1 |
| GOLD | 8 [hp_X]/1 |
| HELLEBORUS NIGER ROOT | 6 [hp_X]/1 |
| PHOSPHORIC ACID | 6 [hp_X]/1 |
| SCUTELLARIA LATERIFLORA | 6 [hp_X]/1 |
| THUJA OCCIDENTALIS LEAFY TWIG | 6 [hp_X]/1 |
Harmonized Identifiers#
Field, Values table| Field | Values |
|---|
| Unii | 7E889U5RNN, 4N9P6CC1DX, YKH834O4BH, 19FUJ2C58T, 79Y1949PYO, 608DGJ6815, E4GA8884NN, 7BP4DH5PDC, 1NT28V9397 |
DailyMed Product Concepts#
DailyMed Package Descriptions#
Package NDC, Product, Description table| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|
| 17312-170-14 | Chronic Fatigue Therapy | 70 in 1 BOTTLE | TABLET, ORALLY DISINTEGRATING | 70 | | 2 |
| 17312-170-14 | Chronic Fatigue Therapy | 1 in 1 PACKAGE | TABLET, ORALLY DISINTEGRATING | 1 | | 2 |
DailyMed Dashboard NDC Coverage#
NDC, Dashboard title, SPL version table| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|
| 17312-170 | CHRONIC FATIGUE THERAPY (EPINEPHRINE, GOLD, CHELIDONIUM MAJUS, ECHINACEA, GINKGO, HELLEBORUS NIGER, PHOSPHORIC ACID, SCUTELLARIA LATERIFLORA, THUJA OCCIDENTALIS) TABLET, ORALLY DISINTEGRATING [TRP COMPANY] | 1 | Current NDC, Legacy NDC, 2 package rows | 20180905_751334b8-f21b-3f94-e053-2a91aa0a9bb9.zip |
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 17312-170-14 | 17312017014 | 1 BOTTLE in 1 PACKAGE (17312-170-14) / 70 TABLET, ORALLY DISINTEGRATING in 1 BOTTLE | 1 bottle | 2018-08-20 | 0000-00-00 | No | No | Current |